2m 2m 2m 2m 2m 2m 2m
ProQR Therapeut (PRQR)
NASDAQ
$1.42-$0.05 (-3.40%)
Price as of Jun 03, 2026 7:23 PM EDT- $166.2MMarket Cap
- -17.42%1-Year Change
- BiotechnologyIndustry
ProQR Therapeut (PRQR)
$1.42-$0.05 (-3.40%)
PRQR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.47 | ||
Change | +$0.05 (+3.52%) | ||
Open | $1.44 | ||
High | $1.50 | ||
Low | $1.35 | ||
Previous Close | $1.42 | ||
Volume | 1,138,298 | ||
30-Day Average Volume | 570,083 | ||
1-Week Change | -6.37% | ||
1-Month Change | -5.16% | ||
1-Year Change | -17.42% | ||
3-Year Change | -22.22% | ||
5-Year Change | -75.98% | ||
Fundamentals | |||
Shares Outstanding | 105.2M | ||
Total Assets | $112.8M | ||
Market Cap | $166.2M | ||
Enterprise Value | $73.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue